Ahmed Salah Arafa *, Ahmed yehia , Alaa fiad
1Magdy Salah El-Din Hussain, 1Hisham Wefky Anwar, 2Mostafa Mahmoud El Nakib, 1Amr Essam Mosaad*
Doaa Ahmed Mansour M.D., FRCS Eng
Moutaz Ragab1,Mohamed Hamed Abouelfadl1, Mahmoud M. Marei 1
Moutaz Ragab, Mahmoud M. Marei ,Mohamed Hamed Abouelfadl
Wadie Boshra MD, MRCS, Mohammed Attia Elsayed MD, Ahmed S. M. Omar MD.
Mahmoud Alhussinia, M. Ashraf Balbaab, Ahmed Tarek Awada, Tamer Abdelbakia
Ahmed El-Gendi1, Mohamed El-Shafei2, Essam Bedewy3
Elsobky A, MD
Ahmed Sawaby1, Islam Atta2, Amr El Abd3,Mohsen Ahmed Abdelmohsen4
Ayman M. A. Osman1 MD, MRCS (Eng); Hytham H. Mohey1 M.Sc.; Ahmed M. Ghobashy1 MD
Nezar A. Abo Halawa1*, Ahmed El-Abd Ahmed2, Sawsan A. Elkhateeb3, Galal H. Galal3
Nezar A. Abo Halawa1*, Mohamed Yousef Batikhe2
Wadie Boshra MD, MRCS, Abdallah Hamed Ibrahim Khalil MD, Fawzy Salah Fawzy MD, MRCS
Hussein Ali Mustafa Abdel-Motaleb, Mohammed Ahmed Mohammed Ismail, Islam Mohamed Nabil Atta & Ahmed Mohammed Ahmed Abdel-Rahim*
Reem Mohamed Ali Abd El Reheem El Masry1, Sameh Abd Allah Maaty2, Anwar A. El Shenawy3, Fawzy Salah Fawzy2
Ultrasound guided sclerotherapy injection of subulcer venous plexus for treatment of chronic venous ulcer
Objectives: Venous hypertension contribute to venous ulceration. We sought to describe patient
characteristics and procedural factors that impact rates of sub ulcer venous plexus (SUV) thrombosis
through injection with ultrasound-guided sclerotherapy (UGS) for the healing of venous ulcers without
axial reflux. Material and Methods: Retrospective review of UGS of SUV injections from 2/2018–9/2018
identified 47 treated venous ulcers in 47 patients. Patients had no other superficial/axial reflux and were
treated with standard wound care and compression therapy for three months. Ultrasound was used to
screen for venous plexus beneath and near ulcer(s), superficial to deep fascia, and these were injected with
polidocanol foam and assessed for thrombosis. Demographic data, comorbidities, treatment details and
outcomes were analyzed. Univariate and multivariable modeling was performed to determine covariates
predicting SUV thrombosis and ulcer healing. Results: 47 patients with active ulcers for an average of 8
months with compression therapy prior to subulcer plexus treatment had an average age of 44 years, were
85% male and 78.7% had a history of DVT. Ulcers were treated with SUV injections, with average
successful closure rate of 85%. Of 47 ulcers, 38 patients (80.9%) healed ulcers, while 9 patients (19.1%)
had non-healed ulcer(s) in mean follow-up of 3 months. Patients that healed ulcers had an SUV closure
rate of 97.4 % vs. 33.3% in patients who did not heal (P<.001). Multivariate models demonstrated initial
ulcer size and ulcer duration negatively predicted thrombosis of SUV .Multivariate model for ulcer healing
found complete SUV thrombosis was a positive predictor (P=.001), while repeated injection sessions was a
negative predictor (P=.007). Conclusions: Thrombosis of SUV with UGS increases venous ulcer healing in
a difficult patient population. Complete closure of all SUVs in an ulcerated limb was the only predictor of
ulcer healing. The failure of complete closure after first session have decreased rates of SUV thrombosis
with UGS.
Keywords: Venous ulcer, ultrasound guided, sclerotherapy injection.